The clinical-stage biopharmaceutical company said its board approved a workforce reduction of 57%, bringing its employee count down to 19. It also decided to exit its corporate headquarters in ...

Arbutus Biopharma (ABUS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.12 per share a year ago. These figures ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Xeris ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce the appointment of Terry Lynch to its board of directors. Mr. Lynch will be ...

Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 11.76%, which has investors questioning if this is right time to sell.

Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous ...

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 94,200 shares, a drop of 62.4% ...

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face ...

NEWARK, CA / ACCESS Newswire / March 18, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company"), a clinical-stage biopharmaceutical company pioneering the discovery and development of ...

The Clinical Trials Arena team investigates the impact of government-led research funding cuts in clinical trials.

Biotech firm Atai is the latest publicly traded company to announce a Bitcoin treasury strategy, starting with a $5 million ...